NANCY LOVERN: Open Payments
NPI 1508333055 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 26 payments from 8 companies in 2025. Trend: 2023 $410 · 2024 $449 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| Lilly USA, LLC | 4 | $76 |
| Exact Sciences Corporation | 2 | $54 |
| Amgen Inc. | 3 | $54 |
| Novo Nordisk Inc | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, Kerendia, REPATHA, The Cologuard Plus Collection Kit, MOUNJARO, JARDIANCE, Ozempic, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
